CBAY
Cymabay Therapeutics Inc
Price:  
32.48 
USD
Volume:  
8,356,540.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CBAY Stock Forecast & Price Target

CBAY Stock Price Forecast

The average stock forecast for Cymabay Therapeutics Inc (CBAY) in the next 12 months is 33.15 USD. This price target corresponds to an upside of 2.06%. The range of stock forecasts for CBAY is 32.83 - 34.13 USD. Based on the ratings of 16 analysts, the consensus recommendation for CBAY is HOLD.
Target Low Average Median High
Price (USD) 32.83 33.15 33.15 34.13
Upside 1.06% 2.06% 2.06% 5.06%

Recommendation Trends

The latest consensus rating for CBAY is "HOLD". This is the average recommendation of 16 analysts: 2 strong sell, 1 sell, 13 hold, 0 buy, 0 strong buy. In the previous period, 19 analysts also majorly recommmended "BUY" for CBAY.

CBAY Financial Stock Forecast

Revenue This Year
11.96M
-61.51%
from 31.07M
Revenue Next Year
116.93M
877.59%
from 11.96M
EPS This Year
-1.46
58.79%
from -0.92
EPS Next Year
-1.06
-27.14%
from -1.46